{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T20:51:37.660114+00:00","published_at":"2026-10-17T04:46:20.15485+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:jcuctqlxi2ba","event_type":"CEO_CHANGED","effective_at":"2026-04-28","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:alan-h-auerbach","alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:8c03f08b0feac396784f5f2734e40180882982f14c6f06eb4fc6773ee20f3f72"],"summary":"Alan H. Auerbach executive of PUMA BIOTECHNOLOGY, INC., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1k8kfnpbdj0mp","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-28","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:douglas-hunt","alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:83caceb8d9eb532756597884e9761a00b2b5d6fe5d4345e13d15fe1fe66c7489"],"summary":"Douglas Hunt executive of PUMA BIOTECHNOLOGY, INC., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:13y53f1tkrekt","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-28","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:jeff-j-ludwig","alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:1adae5c2302d97ca31f0a28b76c4b291e9f19e33f06d6d0c8bf5e8ae15341be1"],"summary":"Jeff J. Ludwig executive of PUMA BIOTECHNOLOGY, INC., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:gosiwyqdsx9e","event_type":"CFO_CHANGED","effective_at":"2026-04-28","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:maximo-f-nougues","alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:000607ef1ff186b50b02dc30ab3be7e013e54293a62a75b8cff336f71cf8daab"],"summary":"Maximo F. Nougues executive of PUMA BIOTECHNOLOGY, INC., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1aej4m0mvw2v4","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:alessandra-cesano-m-d-ph-d","alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c"],"summary":"Alessandra Cesano, M.D., Ph.D. seat on PUMA BIOTECHNOLOGY, INC., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ayusc41smgxni","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:allison-dorval","alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c"],"summary":"Allison Dorval seat on PUMA BIOTECHNOLOGY, INC., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:sxlt2z16sj9qp","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:allison-dorval","alpha:committee:puma-biotechnology-inc:audit"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:committee_record:16"],"evidence_ids":["alpha:projection-evidence:174a17566c16983b0bf4c35c63bbfb7757f47978853a0282977dad1ba2f0a3f9"],"summary":"Allison Dorval member of Audit, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1gme3s41ctlg0s","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:brian-stuglik-r-ph","alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c"],"summary":"Brian Stuglik, R.Ph. seat on PUMA BIOTECHNOLOGY, INC., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:dfxkka1v9n4ye","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:michael-p-miller","alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c"],"summary":"Michael P. Miller seat on PUMA BIOTECHNOLOGY, INC., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1pxyi20lob5s2","event_type":"COMMITTEE_CREATED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:committee:puma-biotechnology-inc:compensation-nominating-and-governance","alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c"],"summary":"Compensation; Nominating and Governance committee of PUMA BIOTECHNOLOGY, INC., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:tnoigi1894b5c","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:michael-p-miller","alpha:committee:puma-biotechnology-inc:compensation-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c"],"summary":"Michael P. Miller member of Compensation; Nominating and Governance, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:die7i71oh5axz","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:adrian-m-senderowicz-m-d","alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c"],"summary":"Adrian M. Senderowicz, M.D. seat on PUMA BIOTECHNOLOGY, INC., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:hy4fd6n1uiog","event_type":"DIRECTOR_APPOINTED","effective_at":"2013-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:troy-e-wilson-ph-d-j-d-2","alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c"],"summary":"Troy E. Wilson, Ph.D., J.D. seat on PUMA BIOTECHNOLOGY, INC., effective 2013-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:2b48we17x564g","event_type":"DIRECTOR_APPOINTED","effective_at":"2012-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:jay-m-moyes","alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c"],"summary":"Jay M. Moyes seat on PUMA BIOTECHNOLOGY, INC., effective 2012-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1mw000mnc8klc","event_type":"COMMITTEE_CREATED","effective_at":"2012-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:committee:puma-biotechnology-inc:audit-chair-compensation","alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c"],"summary":"Audit · Chair; Compensation committee of PUMA BIOTECHNOLOGY, INC., effective 2012-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1sydnom1ra4s20","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2012-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:jay-m-moyes","alpha:committee:puma-biotechnology-inc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c"],"summary":"Jay M. Moyes member of Audit · Chair; Compensation, effective 2012-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:5","subject_id":"alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:adrian-m-senderowicz-m-d","object_label":"Adrian M. Senderowicz, M.D.","object_source_name_forms":[],"value":"Adrian M. Senderowicz, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:adrian-m-senderowicz-m-d","name":"Adrian M. Senderowicz, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PUMA BIOTECHNOLOGY, INC. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925013337/pbyi20250307c_def14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:42:01.735+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:6","subject_id":"alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:alessandra-cesano-m-d-ph-d","object_label":"Alessandra Cesano, M.D., Ph.D.","object_source_name_forms":[],"value":"Alessandra Cesano, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:alessandra-cesano-m-d-ph-d","name":"Alessandra Cesano, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PUMA BIOTECHNOLOGY, INC. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925013337/pbyi20250307c_def14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:42:01.735+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:7","subject_id":"alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:allison-dorval","object_label":"Allison Dorval","object_source_name_forms":[],"value":"Allison Dorval: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:allison-dorval","name":"Allison Dorval"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PUMA BIOTECHNOLOGY, INC. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925013337/pbyi20250307c_def14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:42:01.735+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:8","subject_id":"alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:brian-stuglik-r-ph","object_label":"Brian Stuglik, R.Ph.","object_source_name_forms":[],"value":"Brian Stuglik, R.Ph.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:brian-stuglik-r-ph","name":"Brian Stuglik, R.Ph."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PUMA BIOTECHNOLOGY, INC. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925013337/pbyi20250307c_def14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:42:01.735+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:9","subject_id":"alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jay-m-moyes","object_label":"Jay M. Moyes","object_source_name_forms":[],"value":"Jay M. Moyes: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jay-m-moyes","name":"Jay M. Moyes"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2012-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2012-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PUMA BIOTECHNOLOGY, INC. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925013337/pbyi20250307c_def14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:42:01.735+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2012-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:10","subject_id":"alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-p-miller","object_label":"Michael P. Miller","object_source_name_forms":[],"value":"Michael P. Miller: Director, Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-p-miller","name":"Michael P. Miller"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PUMA BIOTECHNOLOGY, INC. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925013337/pbyi20250307c_def14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:42:01.735+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:11","subject_id":"alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:troy-e-wilson-ph-d-j-d-2","object_label":"Troy E. Wilson, Ph.D., J.D.","object_source_name_forms":[],"value":"Troy E. Wilson, Ph.D., J.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:troy-e-wilson-ph-d-j-d-2","name":"Troy E. Wilson, Ph.D., J.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2013-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2013-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PUMA BIOTECHNOLOGY, INC. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925013337/pbyi20250307c_def14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:42:01.735+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2013-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:12","subject_id":"alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:alan-h-auerbach","object_label":"Alan H. Auerbach","object_source_name_forms":[],"value":"Alan H. Auerbach: President, Chief Executive Officer and Chairman of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:alan-h-auerbach","name":"Alan H. Auerbach"},"title":"President, Chief Executive Officer and Chairman of the Board","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:8c03f08b0feac396784f5f2734e40180882982f14c6f06eb4fc6773ee20f3f72","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PBYI DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926013671/pbyi20260415_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T06:42:16.119523+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:13","subject_id":"alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:douglas-hunt","object_label":"Douglas Hunt","object_source_name_forms":[],"value":"Douglas Hunt: Chief Regulatory Affairs, Medical Affairs and Pharmacovigilance Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:douglas-hunt","name":"Douglas Hunt"},"title":"Chief Regulatory Affairs, Medical Affairs and Pharmacovigilance Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:83caceb8d9eb532756597884e9761a00b2b5d6fe5d4345e13d15fe1fe66c7489","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PBYI DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926013671/pbyi20260415_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T06:42:17.109267+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:14","subject_id":"alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jeff-j-ludwig","object_label":"Jeff J. Ludwig","object_source_name_forms":[],"value":"Jeff J. Ludwig: Chief Commercial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jeff-j-ludwig","name":"Jeff J. Ludwig"},"title":"Chief Commercial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:1adae5c2302d97ca31f0a28b76c4b291e9f19e33f06d6d0c8bf5e8ae15341be1","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PBYI DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926013671/pbyi20260415_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T06:42:17.587902+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:leadership_role:15","subject_id":"alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:maximo-f-nougues","object_label":"Maximo F. Nougues","object_source_name_forms":[],"value":"Maximo F. Nougues: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:maximo-f-nougues","name":"Maximo F. Nougues"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:000607ef1ff186b50b02dc30ab3be7e013e54293a62a75b8cff336f71cf8daab","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PBYI DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926013671/pbyi20260415_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T06:42:16.619621+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:31db5f20-3835-4055-8ac3-64182f3114a3:committee_record:16","subject_id":"alpha:company:31db5f20-3835-4055-8ac3-64182f3114a3","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Jay M. Moyes; Members Jay M. Moyes (Chair); Allison Dorval","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Jay M. Moyes","members":[{"display_name":"Jay M. Moyes","person_slug":"jay-m-moyes","is_chair":true},{"display_name":"Allison Dorval","person_slug":"allison-dorval","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:174a17566c16983b0bf4c35c63bbfb7757f47978853a0282977dad1ba2f0a3f9","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925013337/pbyi20250307c_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:497826d9839c311f9577fe5010887b0d53e00b11aa51b210f7763bac56f4602c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PUMA BIOTECHNOLOGY, INC. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925013337/pbyi20250307c_def14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:42:01.735+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:8c03f08b0feac396784f5f2734e40180882982f14c6f06eb4fc6773ee20f3f72","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PBYI DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926013671/pbyi20260415_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T06:42:16.119523+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:83caceb8d9eb532756597884e9761a00b2b5d6fe5d4345e13d15fe1fe66c7489","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PBYI DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926013671/pbyi20260415_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T06:42:17.109267+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:1adae5c2302d97ca31f0a28b76c4b291e9f19e33f06d6d0c8bf5e8ae15341be1","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PBYI DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926013671/pbyi20260415_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T06:42:17.587902+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:000607ef1ff186b50b02dc30ab3be7e013e54293a62a75b8cff336f71cf8daab","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PBYI DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926013671/pbyi20260415_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T06:42:16.619621+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:174a17566c16983b0bf4c35c63bbfb7757f47978853a0282977dad1ba2f0a3f9","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925013337/pbyi20250307c_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.842,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.887,"cross_source_agreement":0.75,"temporal_completeness":0.688},"diagnostics":{"published_claims":23,"factual_claims":23,"claims_with_linked_evidence":23,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":16,"temporal_claims_with_valid_from":11,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:20.15485+00:00","observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":"2026-10-17T04:46:20.15485+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":23,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/puma-biotechnology-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/puma-biotechnology-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}